0001209191-18-020351.txt : 20180316
0001209191-18-020351.hdr.sgml : 20180316
20180316181055
ACCESSION NUMBER: 0001209191-18-020351
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20180316
DATE AS OF CHANGE: 20180316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cumbo Alexander
CENTRAL INDEX KEY: 0001685994
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 18696954
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-15
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001685994
Cumbo Alexander
215 FIRST STREET
SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
SVP, Chief Commercial Officer
Common Stock
2018-03-15
4
M
0
241
13.71
A
23699
D
Common Stock
2018-03-15
4
F
0
40
81.22
D
23659
D
Common Stock
2018-03-15
4
M
0
54
13.71
A
23713
D
Common Stock
2018-03-15
4
F
0
9
81.22
D
23704
D
Common Stock
2018-03-15
4
M
0
835
13.90
A
24539
D
Common Stock
2018-03-15
4
F
0
142
81.22
D
24397
D
Common Stock
2018-03-15
4
M
0
1370
26.24
A
25767
D
Common Stock
2018-03-15
4
F
0
442
81.22
D
25325
D
Stock option (right to buy)
13.71
2018-03-15
4
M
0
241
0.00
D
2017-02-28
2026-02-28
Common Stock
241
1485
D
Stock option (right to buy)
13.71
2018-03-15
4
M
0
54
0.00
D
2017-02-28
2026-02-28
Common Stock
54
6107
D
Stock option (right to buy)
13.90
2018-03-15
4
M
0
835
0.00
D
2016-02-27
2025-02-27
Common Stock
835
5001
D
Stock option (right to buy)
26.24
2018-03-15
4
M
0
1370
0.00
D
2014-01-02
2023-01-02
Common Stock
1370
11415
D
The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an "option swap" enables the exercise and holding of shares of Common Stock by the Reporting Person.
/s/ David Tyronne Howton, as Attorney-in-Fact for Alexander Cumbo
2018-03-16